Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD16-negative, CD56-bright natural killer cell, human | 7 studies | 22% ± 6% | |
natural killer cell | 7 studies | 20% ± 6% | |
endothelial cell | 5 studies | 21% ± 8% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 3% | |
mature NK T cell | 3 studies | 17% ± 1% | |
astrocyte | 3 studies | 33% ± 13% | |
oligodendrocyte | 3 studies | 29% ± 9% |
Insufficient scRNA-seq data for expression of AGK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1711.88 | 180 / 180 | 100% | 10.02 | 430 / 430 |
prostate | 100% | 2165.80 | 245 / 245 | 100% | 9.27 | 502 / 502 |
lung | 100% | 2019.29 | 578 / 578 | 100% | 9.55 | 1154 / 1155 |
brain | 100% | 2383.06 | 2638 / 2642 | 100% | 12.38 | 705 / 705 |
breast | 100% | 1702.56 | 459 / 459 | 100% | 10.14 | 1116 / 1118 |
kidney | 100% | 1804.84 | 89 / 89 | 100% | 9.38 | 899 / 901 |
skin | 100% | 1670.34 | 1809 / 1809 | 99% | 12.84 | 469 / 472 |
thymus | 100% | 2285.92 | 653 / 653 | 99% | 8.23 | 600 / 605 |
uterus | 100% | 1935.09 | 170 / 170 | 99% | 8.87 | 454 / 459 |
adrenal gland | 100% | 1866.38 | 258 / 258 | 99% | 7.86 | 227 / 230 |
bladder | 100% | 1630.38 | 21 / 21 | 99% | 8.75 | 497 / 504 |
stomach | 100% | 1625.90 | 359 / 359 | 99% | 8.16 | 282 / 286 |
intestine | 100% | 1861.03 | 966 / 966 | 98% | 8.30 | 519 / 527 |
esophagus | 100% | 1736.93 | 1445 / 1445 | 98% | 8.68 | 180 / 183 |
pancreas | 100% | 1007.17 | 327 / 328 | 98% | 6.82 | 174 / 178 |
liver | 100% | 1166.51 | 226 / 226 | 90% | 4.51 | 364 / 406 |
adipose | 100% | 1513.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.99 | 29 / 29 |
spleen | 100% | 2675.26 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.25 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.04 | 1 / 1 |
blood vessel | 100% | 1522.36 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 1576.34 | 857 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 685.66 | 781 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 5.96 | 76 / 80 |
peripheral blood | 76% | 1297.80 | 706 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046486 | Biological process | glycerolipid metabolic process |
GO_0045039 | Biological process | protein insertion into mitochondrial inner membrane |
GO_0046834 | Biological process | lipid phosphorylation |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0042721 | Cellular component | TIM22 mitochondrial import inner membrane insertion complex |
GO_0005758 | Cellular component | mitochondrial intermembrane space |
GO_0005829 | Cellular component | cytosol |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0047620 | Molecular function | acylglycerol kinase activity |
GO_0004143 | Molecular function | ATP-dependent diacylglycerol kinase activity |
GO_0102773 | Molecular function | dihydroceramide kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0001729 | Molecular function | ceramide kinase activity |
Gene name | AGK |
Protein name | Acylglycerol kinase, mitochondrial Acylglycerol kinase, mitochondrial (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) Acylglycerol kinase Acylglycerol kinase, mitochondrial (hAGK) (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (HsMuLK) (MuLK) (Multi-substrate lipid kinase) |
Synonyms | MULK |
Description | FUNCTION: Lipid kinase that can phosphorylate both monoacylglycerol and diacylglycerol to form lysophosphatidic acid (LPA) and phosphatidic acid (PA), respectively . Does not phosphorylate sphingosine . Phosphorylates ceramide (By similarity). Phosphorylates 1,2-dioleoylglycerol more rapidly than 2,3-dioleoylglycerol (By similarity). Independently of its lipid kinase activity, acts as a component of the TIM22 complex . The TIM22 complex mediates the import and insertion of multi-pass transmembrane proteins into the mitochondrial inner membrane by forming a twin-pore translocase that uses the membrane potential as the external driving force . In the TIM22 complex, required for the import of a subset of metabolite carriers into mitochondria, such as ANT1/SLC25A4 and SLC25A24, while it is not required for the import of TIMM23 . Overexpression increases the formation and secretion of LPA, resulting in transactivation of EGFR and activation of the downstream MAPK signaling pathway, leading to increased cell growth . . |
Accessions | A0A3B3ITD0 A0A3B3ISY9 ENST00000494688.1 ENST00000573706.5 ENST00000650365.1 A0A0G2JLD0 A0A3B3IUC9 A0A3B3IS09 ENST00000492693.5 [Q53H12-2] A0A3B3ITV0 A0A3B3ISZ0 ENST00000473247.5 ENST00000648690.1 ENST00000648068.1 [Q53H12-1] ENST00000649014.1 ENST00000650006.1 Q53H12 A0A3B3IRM6 E9PG39 ENST00000649790.1 A0A0G2JLG5 ENST00000473884.5 ENST00000649286.2 [Q53H12-1] ENST00000648395.1 ENST00000647568.1 ENST00000629555.2 A0A3B3ITX7 ENST00000575872.2 ENST00000650547.1 [Q53H12-1] F8WDD1 ENST00000573803.5 ENST00000649365.1 E9PC15 ENST00000649914.1 |